As of 2025-05-03, the Relative Valuation of Medifast Inc (MED) is 5.56 USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.25 USD, the upside of Medifast Inc based on Relative Valuation is -58.0%.
The range of the Relative Valuation is 3.58 - 9.19 USD.
| Range | Selected | |
| Trailing P/E multiples | 18.7x - 23.4x | 21.2x |
| Forward P/E multiples | 15.2x - 22.1x | 17.0x |
| Fair Price | 3.58 - 9.19 | 5.56 |
| Upside | -73.0% - -30.6% | -58.0% |
| Date | P/E |
| 2025-05-02 | 69.29 |
| 2025-05-01 | 67.88 |
| 2025-04-30 | 68.71 |
| 2025-04-29 | 65.37 |
| 2025-04-28 | 65.79 |
| 2025-04-25 | 64.53 |
| 2025-04-24 | 63.64 |
| 2025-04-23 | 63.38 |
| 2025-04-22 | 64.11 |
| 2025-04-21 | 62.75 |
| 2025-04-17 | 62.33 |
| 2025-04-16 | 63.54 |
| 2025-04-15 | 64.74 |
| 2025-04-14 | 67.56 |
| 2025-04-11 | 66.47 |
| 2025-04-10 | 68.71 |
| 2025-04-09 | 68.51 |
| 2025-04-08 | 65.73 |
| 2025-04-07 | 68.09 |
| 2025-04-04 | 68.98 |
| 2025-04-03 | 68.30 |
| 2025-04-02 | 71.43 |
| 2025-04-01 | 68.71 |
| 2025-03-31 | 70.49 |
| 2025-03-28 | 72.32 |
| 2025-03-27 | 73.26 |
| 2025-03-26 | 71.54 |
| 2025-03-25 | 72.48 |
| 2025-03-24 | 74.00 |
| 2025-03-21 | 74.99 |
| 2025-03-20 | 75.09 |
| 2025-03-19 | 73.94 |
| 2025-03-18 | 76.09 |
| 2025-03-17 | 75.04 |
| 2025-03-14 | 72.90 |
| 2025-03-13 | 72.53 |
| 2025-03-12 | 73.47 |
| 2025-03-11 | 74.94 |
| 2025-03-10 | 78.65 |
| 2025-03-07 | 75.51 |
| 2025-03-06 | 71.90 |
| 2025-03-05 | 73.68 |
| 2025-03-04 | 74.42 |
| 2025-03-03 | 73.32 |
| 2025-02-28 | 75.09 |
| 2025-02-27 | 73.11 |
| 2025-02-26 | 74.99 |
| 2025-02-25 | 75.25 |
| 2025-02-24 | 77.24 |
| 2025-02-21 | 77.03 |